HCPCS Codes Similar to M1190

HCPCS Codes Similar to “M1190” Code.
Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr)

M1189 Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON	G8775 Documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) Code added date: 20120101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON
G8776 Serum creatinine test not performed, reason not given Code added date: 20120101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON	G8774 Serum creatinine test result documented and reviewed Code added date: 20120101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON
G9722 Documented history of renal failure or baseline serum creatinine >= 4.0 mg/dl; renal transplant recipients are not considered to have preoperative renal failure, unless, since transplantation the cr has been or is 4.0 or higher Code added date: 20170101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON	G9840 Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab Code added date: 20170101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
G9841 Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab Code added date: 20170101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	G9839 Anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G9844 Patient did not receive anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9845 Patient received anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
M1412 Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	A9524 Iodine i-131 iodinated serum albumin, diagnostic, per 5 microcuries Code added date: 20030101 Code effective date: 20060101 TXT \| PDF \| XML \| JSON
A9532 Iodine i-125 serum albumin, diagnostic, per 5 microcuries Code added date: 20040101 Code effective date: 20060101 TXT \| PDF \| XML \| JSON	A9540 Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries Code added date: 20060101 Code effective date: 20060101 TXT \| PDF \| XML \| JSON